- LncRNA ANRIL promotes multiple myeloma progression and bortezomib res…
Number of the records: 1  

LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN

  1. LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN / Li-Hui Yang ... [et al.]. Neoplasma Vol. 68, no. 4 (2021), s. 788-797
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all